glp 1 drug novo nordisk Details of failed studies cast pall on Nordisk's GLP-1 as Alzheimer's treatment Novo Nordisk hikes full-year forecast

Eli Lillys oral GLP-1 candidate orforglipron met all primary and secondary endpoints in a Phase 3 study of adults with type 2 diabetes, the

Supresa Saffron Extract: Standardized to 0.3% safranal, this extract has been associated with a 69% decrease in hunger and a 55% reduction in snacking events over an eight-week period

A 4-day meal plan consisting of foods that naturally increase the production of GLP-1 in the body: well-balanced meals that support the gut microbiome.

This article delves into key considerations and challenges health insurers face.

A Breakthrough Award, New Evidence in Parkinson's and Heart Disease

Modern prescription weight loss medications: Wegovy, Ozempic, Mounjaro, Zepbound.